These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15620634)

  • 1. Inflammatory diseases: is ubiquitinated NEMO at the hub?
    Burns KA; Martinon F
    Curr Biol; 2004 Dec; 14(24):R1040-2. PubMed ID: 15620634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO.
    Abbott DW; Wilkins A; Asara JM; Cantley LC
    Curr Biol; 2004 Dec; 14(24):2217-27. PubMed ID: 15620648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.
    Girardin SE; Boneca IG; Viala J; Chamaillard M; Labigne A; Thomas G; Philpott DJ; Sansonetti PJ
    J Biol Chem; 2003 Mar; 278(11):8869-72. PubMed ID: 12527755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crohn's disease is caused by mutations in the bacterial response protein NOD2.
    Press RD
    Mol Diagn; 2001 Dec; 6(4):347-8. PubMed ID: 11837220
    [No Abstract]   [Full Text] [Related]  

  • 5. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing.
    Maeda S; Hsu LC; Liu H; Bankston LA; Iimura M; Kagnoff MF; Eckmann L; Karin M
    Science; 2005 Feb; 307(5710):734-8. PubMed ID: 15692052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordinated regulation of Toll-like receptor and NOD2 signaling by K63-linked polyubiquitin chains.
    Abbott DW; Yang Y; Hutti JE; Madhavarapu S; Kelliher MA; Cantley LC
    Mol Cell Biol; 2007 Sep; 27(17):6012-25. PubMed ID: 17562858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease.
    Inohara N; Ogura Y; Fontalba A; Gutierrez O; Pons F; Crespo J; Fukase K; Inamura S; Kusumoto S; Hashimoto M; Foster SJ; Moran AP; Fernandez-Luna JL; Nuñez G
    J Biol Chem; 2003 Feb; 278(8):5509-12. PubMed ID: 12514169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor-{kappa}B activation in muramyl dipeptide recognition.
    Barnich N; Aguirre JE; Reinecker HC; Xavier R; Podolsky DK
    J Cell Biol; 2005 Jul; 170(1):21-6. PubMed ID: 15998797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nod2 and Crohn's disease: many connected highways.
    Meinzer U; Hugot JP
    Lancet; 2005 May 21-27; 365(9473):1752-4. PubMed ID: 15910938
    [No Abstract]   [Full Text] [Related]  

  • 10. ITCH K63-ubiquitinates the NOD2 binding protein, RIP2, to influence inflammatory signaling pathways.
    Tao M; Scacheri PC; Marinis JM; Harhaj EW; Matesic LE; Abbott DW
    Curr Biol; 2009 Aug; 19(15):1255-63. PubMed ID: 19592251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOD takes its toll but stays in the CARDs in Crohn's disease.
    Luft FC
    J Mol Med (Berl); 2005 Aug; 83(8):577-8. PubMed ID: 16010582
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations.
    Li J; Moran T; Swanson E; Julian C; Harris J; Bonen DK; Hedl M; Nicolae DL; Abraham C; Cho JH
    Hum Mol Genet; 2004 Aug; 13(16):1715-25. PubMed ID: 15198989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease.
    van Heel DA; Ghosh S; Butler M; Hunt KA; Lundberg AM; Ahmad T; McGovern DP; Onnie C; Negoro K; Goldthorpe S; Foxwell BM; Mathew CG; Forbes A; Jewell DP; Playford RJ
    Lancet; 2005 May 21-27; 365(9473):1794-6. PubMed ID: 15910952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NOD2-RICK complex signals from the plasma membrane.
    Lécine P; Esmiol S; Métais JY; Nicoletti C; Nourry C; McDonald C; Nunez G; Hugot JP; Borg JP; Ollendorff V
    J Biol Chem; 2007 May; 282(20):15197-207. PubMed ID: 17355968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nod2 in normal and abnormal intestinal immune function.
    Abreu MT
    Gastroenterology; 2005 Oct; 129(4):1302-4. PubMed ID: 16230083
    [No Abstract]   [Full Text] [Related]  

  • 16. NOD2 3020insC mutation and the pathogenesis of Crohn's disease: impaired IL-1beta production points to a loss-of-function phenotype.
    Netea MG; Ferwerda G; de Jong DJ; Girardin SE; Kullberg BJ; van der Meer JW
    Neth J Med; 2005 Sep; 63(8):305-8. PubMed ID: 16186640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genes, microbes, and T cells--new therapeutic targets in Crohn's disease.
    Elson CO
    N Engl J Med; 2002 Feb; 346(8):614-6. PubMed ID: 11856802
    [No Abstract]   [Full Text] [Related]  

  • 18. A role for Erbin in the regulation of Nod2-dependent NF-kappaB signaling.
    McDonald C; Chen FF; Ollendorff V; Ogura Y; Marchetto S; Lécine P; Borg JP; Nuñez G
    J Biol Chem; 2005 Dec; 280(48):40301-9. PubMed ID: 16203728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses.
    Watanabe T; Kitani A; Murray PJ; Strober W
    Nat Immunol; 2004 Aug; 5(8):800-8. PubMed ID: 15220916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired innate immunity in Crohn's disease.
    Comalada M; Peppelenbosch MP
    Trends Mol Med; 2006 Sep; 12(9):397-9. PubMed ID: 16890491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.